12 organizations in Longevity

Aging biology research with a dedicated female-physiology track.

Operator network convening founders and clinical leaders.

Annual gathering of operators, clinicians, and investors.

Smart ring for health, sleep, menstrual & pregnancy tracking; ~$11B valuation.

Wearable for fitness, recovery, and metabolic-signal tracking.

TruAge™ / TruHealth™ at-home epigenetic DNA-methylation tests; 2025 NIH SBIR for W-Function Epigenomic Roadmap for women's healthspan.

Consumer longevity biotech; CheekAge™ non-invasive buccal epigenetic clock published in GeroScience (Mar 2024).

INDEX™ at-home epigenetic biological-age test (10 aging systems, developed with Dr. Morgan Levine/Yale); Basis nutraceutical (NR + pterostilbene).

$499/yr membership for 100+ blood biomarkers across 21 categories incl. hormones, longevity, metabolic; $53M Series A led by a16z.

$499/yr 'health super app' with biannual 100+ biomarker panels + AI insights; $30M Series A led by Forerunner Ventures.

Telemedicine clinic for hormone optimization & proactive longevity; 300K+ patients tested; acquired ivee in Jan 2025 with $33M Series A.

NIH office funding women's midlife health innovation; 2025 intramural awards spanning menopause, CVD risk, midlife chronic disease.